safeti immunolog respons recombin vaccinia viru vaccin hiv envelop glycoprotein randomis phase trial recombin vaccina viru vaccin envelop gene human immunodefici viru healthi hiv-seroneg male histori smallpox immunis vaccinia naiv week standard NY strain vaccinia viru frequenc durat titr viru isol vaccin site occurr local side-effect similar group vaccine vaccinia-na vac-n subject viru vaccin site titr vaccinia-prim vac-p individu day vs pfu/ml in-vitro t-cell prolif respons hiv antigen prepar vaccinia-prim subject t-cell respons transient subject antibodi hiv detect vaccinia-na subject strong t-cell respons homolog heterolog strain whole viru protein detect year antibodi hiv envelop recombin vaccinia viru vaccin t-cell prime foreign gene product individu sole immunis agent efficaci vaccinia-na individu 